GSO ISO 15223-1:2024

ISO 15223-1:2021
Gulf Standard   Current Edition · Approved on 25 April 2024

Medical devices — Symbols to be used with information to be supplied by the manufacturer — Part 1: General requirements

GSO ISO 15223-1:2024 Files

English 0 Pages
Current Edition Reference Language
195.06 USD

GSO ISO 15223-1:2024 Scope

This document specifies symbols used to express information supplied for a medical device. This document is applicable to symbols used in a broad spectrum of medical devices, that are available globally and need to meet different regulatory requirements.

These symbols can be used on the medical device itself, on its packaging or in the accompanying information. The requirements of this document are not intended to apply to symbols specified in other standards.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 2063:2023
 
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants

Recently Published from Health Sector

GSO ISO 20776-2:2024
ISO 20776-2:2021 
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution
GSO ISO 27186:2024
ISO 27186:2020 
Gulf Standard
Active implantable medical devices — Four-pole connector system for implantable cardiac rhythm management devices — Dimensional and test requirements
GSO ISO 28620:2024
ISO 28620:2020 
Gulf Standard
Medical devices — Non-electrically driven portable infusion devices
GSO ISO 20776-1:2024
ISO 20776-1:2019 
Gulf Standard
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases